Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia

This study has been completed.

Study NCT00390897 Information provided by PETHEMA Foundation

First Received: October 20, 2006 Last Updated: November 26, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2007
Primary Completion Date:	October 2006 (Final data collection date for primary outcome measure)